Marathon Capital Management’s MaxLinear MXL Stock Holding History

Marathon Capital Management’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.56M	Sell	20,000 -2,500	-11%	-$177K	0.52%	50
2026 Q1	$391K	Hold	22,500	–	–	0.09%	122
2025 Q4	$392K	Hold	22,500	–	–	0.08%	123
2025 Q3	$362K	Hold	22,500	–	–	0.08%	113
2025 Q2	$320K	Hold	22,500	–	–	0.08%	116
2025 Q1	$244K	Hold	22,500	–	–	0.07%	131
2024 Q4	$445K	Hold	22,500	–	–	0.11%	99
2024 Q3	$326K	Buy	+22,500	New	+$357K	0.08%	111

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marathon Capital Management's MXL Position: Q2 2026 in Review

Marathon Capital Management reduced its MaxLinear (MXL) stake by 11% in Q2 2026, selling an estimated $177K and leaving 20,000 shares worth $2.56M. The position accounts for 0.52% of the portfolio, ranked #50.

Marathon Capital Management first reported a position in MXL in Q3 2024 and has held it in 8 quarters since. 433 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Marathon Capital Management held 20,000 shares of MaxLinear worth $2.56M as of Q2 2026.
Marathon Capital Management sold 2,500 MaxLinear shares in Q2 2026, an estimated $177K.
MaxLinear made up 0.52% of Marathon Capital Management's portfolio in Q2 2026, its #50 holding.
Marathon Capital Management first reported a position in MaxLinear in Q3 2024 and has held it in 8 quarters since.
433 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.